1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers
- PMID: 9595987
- DOI: 10.1212/wnl.50.5.1357
1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers
Abstract
Huntington's disease (HD) is the result of an expanded (CAG) repeat in a gene on chromosome 4. A consequence of the gene defect may be progressive impairment of energy metabolism. We previously showed increased occipital cortex lactate in HD using localized 1H spectroscopy. We have now extended these studies to show an almost threefold elevation in occipital cortex lactate in 31 HD patients as compared with 17 normal control subjects (p < 10(-11)). The spectra in three presymptomatic gene-positive patients were identical to normal control subjects in cortical regions, but three in eight showed elevated lactate in the striatum. Similar to recently reported increases in task-related activation of the striatum in the dominant hemisphere, we found that striatal lactate levels in HD patients were markedly asymmetric (higher on the left side). Markers of neuronal degeneration, decreased N-acetylaspartate (NAA)/creatine and increased choline/creatine levels, were symmetric. Both decreased NAA and increased lactate in the striatum significantly correlated with duration of symptoms. When divided by his or her age, an individual's striatal NAA loss and lactate increase were found to directly correlate with the subject's CAG repeat number, with correlation coefficients of 0.8 and 0.7, respectively. Similar correlations were noted between postmortem cell loss and age versus CAG repeat length. Together, these data provide further evidence for an interaction between neuronal activation and a defect in energy metabolism in HD that may extend to presymptomatic subjects.
Similar articles
-
Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy.Neurology. 1993 Dec;43(12):2689-95. doi: 10.1212/wnl.43.12.2689. Neurology. 1993. PMID: 8255479
-
Clinical correlation of striatal 1H MRS changes in Huntington's disease.Neurology. 1999 Sep 11;53(4):806-12. doi: 10.1212/wnl.53.4.806. Neurology. 1999. PMID: 10489045
-
N-Acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington's disease mice.Neuroreport. 2000 Nov 27;11(17):3751-7. doi: 10.1097/00001756-200011270-00032. Neuroreport. 2000. PMID: 11117485
-
Glucose transportation in the brain and its impairment in Huntington disease: one more shade of the energetic metabolism failure?Amino Acids. 2017 Jul;49(7):1147-1157. doi: 10.1007/s00726-017-2417-2. Epub 2017 Apr 10. Amino Acids. 2017. PMID: 28396959 Review.
-
The search for sensitive biomarkers in presymptomatic Huntington disease.J Cereb Blood Flow Metab. 2012 May;32(5):769-70. doi: 10.1038/jcbfm.2012.17. Epub 2012 Feb 29. J Cereb Blood Flow Metab. 2012. PMID: 22373644 Free PMC article. Review. No abstract available.
Cited by
-
Potential mechanisms to modify impaired glucose metabolism in neurodegenerative disorders.J Cereb Blood Flow Metab. 2023 Jan;43(1):26-43. doi: 10.1177/0271678X221135061. Epub 2022 Oct 24. J Cereb Blood Flow Metab. 2023. PMID: 36281012 Free PMC article. Review.
-
Acid-sensing ion channels in pain and disease.Nat Rev Neurosci. 2013 Jul;14(7):461-71. doi: 10.1038/nrn3529. Nat Rev Neurosci. 2013. PMID: 23783197 Free PMC article. Review.
-
Neuroprotective and neurorestorative strategies for neuronal injury.Neurotox Res. 2000;2(2-3):71-84. doi: 10.1007/BF03033786. Neurotox Res. 2000. PMID: 16787833
-
Platelet-derived extracellular vesicles in Huntington's disease.J Neurol. 2018 Nov;265(11):2704-2712. doi: 10.1007/s00415-018-9022-5. Epub 2018 Sep 12. J Neurol. 2018. PMID: 30209650
-
The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.J Bioenerg Biomembr. 2010 Jun;42(3):199-205. doi: 10.1007/s10863-010-9286-7. J Bioenerg Biomembr. 2010. PMID: 20556492 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical